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DOI 10.1016/j.ccr.2011.03.022SUMMARYDefective V(D)J rearrangement of immunoglobulin heavy or light chain (IgH or IgL) or class switch recombi-
nation (CSR) can initiate chromosomal translocations. The DNA-damage kinase ATM is required for the
suppression of chromosomal translocations but ATM regulation is incompletely understood. Here, we
show that mice lacking the ATM cofactor ATMIN in B cells (ATMINDB/DB) have impaired ATM signaling and
develop B cell lymphomas. Notably, ATMINDB/DB cells exhibited defective peripheral V(D)J rearrangement
and CSR, resulting in translocations involving the Igh and Igl loci, indicating that ATMIN is required for effi-
cient repair of DNA breaks generated during somatic recombination. Thus, our results identify a role for
ATMIN in regulating the maintenance of genomic stability and tumor suppression in B cells.INTRODUCTION
ATM is the protein kinase that is mutated in the hereditary auto-
somal-recessive disease ataxia telangiectasia (A-T) (Savitsky
et al., 1995). A-T patients display immune deficiencies, cancer
predisposition, neuronal degeneration, and radiosensitivity
(McKinnon, 2004). The molecular role of ATM is to respond to
DNA double-strand breaks (DSBs) and alterations in chromatin
structure by phosphorylating its substrates, thereby promoting
repair of damage or arresting the cell cycle (Xu and Baltimore,
1996). ATM is activated by two known cofactors in a stimulus-
dependent manner. Following the induction of DSBs by ionizing
radiation (IR), NBS1 (mutated in Nijmegen breakage syndrome)
is required for activation of ATM. NBS1 activates ATM as part
of the MRN complex that consists of Mre11 (the exonuclease
mutated in ataxia telangiectasia-like disorder, ATLD) (D’Amours
and Jackson, 2002; Stracker et al., 2004), Rad50, and NBS1
(Lee and Paull, 2004; Uziel et al., 2003).Significance
The DNA-damage kinase ATM has important functions in the s
tion of lymphoid cancers. We have recently identified ATMIN a
dependent manner. Using conditional inactivation of ATMIN in
noncanonical ATM activation results in oncogenic chromosom
translocations occur because programmed breaks generated
leading to a defect in class switch recombination and genomi
there is severe defect in ATM signaling. These findings indica
for ATM function in cancer suppression.ATM can also be activated in the absence of DNA damage.
Treatment of cultured cells with hypotonic stress or chloroquine
leads to the activation of ATM, presumably because these agents
induce changes in chromatin structure (Bakkenist and Kastan,
2003).NBS1null B cells are defective inATM-dependent signaling
following IR, but they show a functional ATM-signaling pathway in
response to osmotic stress (Difilippantonio et al., 2005). We have
recently described a second ATM cofactor, ATMIN for ATM inter-
actor (Kanu and Behrens, 2007), also called ASCIZ for ATM/ATR-
Substrate Chk2-Interacting zinc finger protein (McNees et al.,
2005; Oka et al., 2008). ATMIN interacts with ATM using a motif
homologous to that of NBS1 and in doing so stabilizes ATM at
the protein level (Kanu and Behrens, 2007). ATMIN has a comple-
mentary function to NBS1 with respect to ATM activation: ATMIN
is dispensable for IR-induced ATM signaling, but ATM activation
following chloroquine treatment and hypotonic stress ismediated
by ATMIN (Kanu and Behrens, 2007). Hence, NBS1 and ATMIN
are required for ATM activation in a signal-dependent manner.uppression of chromosomal translocations and the preven-
s an ATM cofactor required for ATM function in a stimulus-
B cells, we demonstrate that ablation of ATMIN-dependent
al translocations and subsequent tumor development. These
during somatic recombination are not repaired effectively,
c instability. Furthermore, B cell maturation is affected, and
te that noncanonical ATM activation is absolutely required
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ATMIN Regulates Genomic StabilityIn addition to functioning as an ATM cofactor, ATMIN has also
been implicated in the DNA-damage response because it forms
Rad51-containing foci in response to DNA-methylating agents,
but not in response to DSB-inducing agents (McNees et al.,
2005). Furthermore, ATMIN-deficient chicken DT40 B lympho-
cytes display markedly increased Ig gene conversion rates;
however, neither the efficiency of DSB repair nor hypermutation
was affected by ATMIN levels, indicating that ATMIN does not
directly control homologous recombination or formation of
abasic sites (Oka et al., 2008).
Physiologically, DNA DSBs are generated in the immune
system during V(D)J recombination by the recombination acti-
vating gene 1/2 (RAG1/2) enzymes. During the maturation of B
cells, DSBs also occur during class switch recombination (CSR)
in a manner that is dependent on activation-induced cytidine
deaminase (AID). DNADSBsgenerated during both V(D)J recom-
bination and CSR rely on nonhomologous end-joining (NHEJ) to
repair the lesions. Indeed, both A-T patients and mice lacking
ATM function are immunocompromised and develop leukemia
and/or lymphoma (Barlow et al., 1996; Callen et al., 2007b;
Camacho et al., 2002; Fang et al., 2003; Haidar et al., 2000;
Schaffner et al., 1999, 2000; Stankovic et al., 2002; Stilgenbauer
et al., 1999; Xu and Baltimore, 1996). Because the knockout
mouse for ATM (ATM/) recapitulates many of the immune
defects exhibited by A-T patients, it is a good model to study
the functions of ATM in the immune system. Specifically for B
cells, ATM/ mice have decreased pre-B cells in the bone
marrow (BM), which is not attributed to fewer progenitors
because similar numbers of lessmature pro-B cells were present
in theBM (Xu et al., 1996). It should be noted that despite thismild
developmental defect of B cells, ATM/ mice display normal
numbers of mature B cells in the spleen (Xu et al., 1996).
AID is the enzyme that initiates both somatic hypermutation
(SHM) and CSR (Muramatsu et al., 2000; Revy et al., 2000) by
deaminating cytidines (Petersen-Mahrt et al., 2002). The deami-
nated cytidines can either lead to mutations associated with the
variable region of Igh or to DSBs within the switch region that
initiate CSR (Neuberger et al., 2003). CSR is reduced by about
75% in ATM/ mice (Lumsden et al., 2004; Reina-San-Martin
et al., 2004). Conversely, SHM is not affected upon deletion of
ATM (Reina-San-Martin et al., 2004), and this is thought to be
because such lesions are repaired through mismatch repair
(MMR) and base excision repair (BER), which are ATM indepen-
dent.AfinalphenotypeofATM/Bcells is lossofgenomicstability
not only of chromosome 12 (which carries the Igh locus) but also
of other loci (Callen et al., 2007b), indicating that ATM functions
in the repair of breaks specifically generated during CSR within
the Igh locus but also in maintaining general genomic stability.
Some of the defects displayed in ATM/mice are not entirely
recapitulated upon deletion of NBS1 in various mouse models.
Whereas the deletion of NBS1 in B cells leads to a reduced
efficiency in CSR, the defect is less pronounced than that dis-
played by ATM mutants (Kracker et al., 2005; Lumsden et al.,
2004; Reina-San-Martin et al., 2004). Also, in a mouse model
harboring mutations within NBS1 that are found in patients with
NBS (hNbs1657D5), thedevelopment ofBcell andTcell lymphoma
occurred only in a p53 null (p53/) background (Difilippantonio
et al., 2005), whereas ATM/ mice develop thymomas with
high penetrance (Xu et al., 1996). Furthermore, homozygous588 Cancer Cell 19, 587–600, May 17, 2011 ª2011 Elsevier Inc.knock-inmice harboring adeletion of ATM that commonly occurs
in A-T patients (7636 del9mutation) did develop B cell lymphoma
(Springet al., 2001), indicating a role forATM in thesuppressionof
B cell lymphoma in mice. Hence, the data from both cellular
models and in vivomodels for ATMandNBS1 indicate a possible
role for MRN-independent activation of ATM.
Although DNA damage-independent ATM activation has been
observed in cultured cells, the physiological relevance of ATMIN-
regulated chromatin-induced ATM activation was unknown. In
this study we test the functional significance of noncanonical
ATM signaling in B cells.
RESULTS
ATMIN Is Required during B Cell Maturation
Due to the embryonic lethality of ATMIN knockout mice (Kanu
et al., 2010), we generated a conditional knockout mouse model
for ATMIN in order to determine whether ATMIN is required for
any of the functions of ATM in B cells. To delete ATMIN in B cells,
we have flanked exon 4 of the atmin gene with loxP sites by
targeted mutation of the atmin locus (ATMINF/F mice) (see
Figure S1A available online). Exon 4 encodes a large portion of
the ATMIN protein (615 of 823 amino acids in murine ATMIN).
We have previously described that mouse embryonic fibroblasts
(MEFs) derived from mice with a homozygous germline deletion
of atmin exon 4 do not express detectable ATMIN protein (Kanu
and Behrens, 2007). Thus, deletion of atmin exon 4 generates
anullmutation.Byexpressingcre-recombinaseunder thecontrol
of the CD19 promoter, ATMIN was deleted from the pro-B cell
stage of development onward (denoted as ATMINDB/DB).
Recombination of the floxed atmin locus by CD19-cre was
confirmed by PCR designed to identify the wild-type (WT),
floxed, and deleted alleles in tail, spleen, BM, and thymus
samples (Figure 1A). Absence of ATMIN protein and mRNA in
B cells was additionally confirmed by western blot and quantita-
tive RT-PCR, respectively, of ATMINF/F and ATMINDB/DB-purified
splenic B cells (Figures 1B and 1C).
In order to determine a possible role for ATMIN in the
maturation of B cells, we analyzed cells from BM and spleen
by FACS in parallel with WT and ATM/ mice. Pre-B cells
(B220+CD43IgM) and immature B cells (B220+CD43IgM+)
were decreased in ATMINDB/DB and ATM/ mice compared
with their littermate controls (Figures 1D and 1E). Recirculating
mature B cells in BM (B220hiCD43IgM+) were not significantly
changed in ATMINDB/DB and ATM/ mice compared with litter-
mate controls (Figures 1D and 1E). The FACS profiles of B220
and CD43 staining of pro-B BM cells are shown in Figures S1B
and S1C. FACS analysis of CD43 (from Figures S1B and S1C)
BM cells stained for B220 and IgM to identify pre-B cells, imma-
ture B cells, and recirculating mature B cells for the individual
mice in Figures 1D and 1E is shown in Figures S1D and S1E.
Analysis of the spleen revealed normal cellularity, normal
frequency of peripheral splenic mature B cells (B220+IgM+),
and normal total numbers of peripheral splenic mature B cells
(B220+IgM+) in ATMINDB/DB and/or ATM/mutantmice (Figures
S1F–S1I). Furthermore, ATMINDB/DB mice did not display
a change in the structure of the spleen by hematoxylin and eosin
staining (H&E) (Figure S1J). Thus, the phenotypes of ATMIN and
ATM deficiency in B cell development share some similarities.
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Figure 1. ATMIN Is Required during B Cell Maturation
(A) Genotyping of atmin WT, floxed, and D alleles by PCR from tail, spleen, BM, and thymus of ATMINF/F, ATMIN+/DB, and ATMINDB/DB mice.
(B) ATMIN is deleted in B cells from ATMINDB/DB mice. Purified B lymphocytes from the spleen of ATMINF/F and ATMINDB/DB mice were blotted with anti-ATMIN
and anti-b-actin antibodies.
(C) To assess ATMIN mRNA levels in B cells of ATMINF/F, ATMIN+/DB, and ATMINDB/DB mice, B cells were sorted as B220+ and then RNA was extracted. Levels
of ATMIN mRNA were normalized to actin.
(D) Pre-B cells (B220+CD43 IgM) denoted as ‘‘(I)’’ and immature B cells (B220+CD43IgM+) denoted as ‘‘(II)’’ are reduced in ATMINDB/DB (n = 5) and ATM/
(n = 3) BM, compared with their controls. Recirculating immature B cells (B220hiCD43IgM+) denoted as ‘‘(III)’’ are unchanged in ATMINDB/DB (n = 5) and ATM/
(n = 3) BM, as determined by FACS.
(E) Quantification of (D). Data are presented as mean and SD. Statistical analyses were calculated by a Student’s t test with two-tailed distribution. p values
are indicated.
See also Figure S1.
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Figure 2. CSR Is Perturbed in ATMINDB/DB
B Lymphocytes
(A) ATMINF/F and ATMINDB/DB or (B) WT and
ATM/-purified splenic B lymphocytes were
stimulated with LPS/IL4 for 3 days and then
stained with anti B220 and IgG1 (n = 4 per geno-
type).
(C) ATMINF/F and ATMINDB/DB-purified splenic B
lymphocytes were stimulated with LPS/IL4 for
3 days in the presence of an ATM inhibitor (ATMi)
and then stained with anti B220 and IgG1 (n = 4 per
genotype).
(D) Data from (A)–(C) are presented as mean and
SD. Statistical analyses were calculated by
a Student’s t test with two-tailed distribution.
p values are indicated. N.S., not significant.
(E) Splenic B cells were purified from ATMINF/F,
ATMINDB/DB, WT, and ATM/ mice and stimu-
lated for 6 days with LPS/IL4 following which
supernatants were analyzed for IgG1 by ELISA
(n = 3 per genotype). Error bars denote SD.
(F) ATMINF/F and ATMINDB/DB mice (n = 4 per
genotype) were immunized with TNP/KLH in FCA,
serum was collected 7 days after a second
immunization, and levels of antigen-specific Igs
were assayed by ELISA. Significant decreases
were observed between the levels of immuno-
globulins in ATMINF/F mice compared with
ATMINDB/DB mice. Data presented as mean and
SD. Statistical analyses were calculated by
a Student’s t test with two-tailed distribution.
p values are indicated.
(G) Mice were immunized as in (F), but levels of
antigen-specific IgM were measured at the
indicated time points after the first immunization
(n = 4 per genotype). Error bars denote SD. No
significant differences were observed between
ATMINF/F and ATMINDB/DB mice calculated by
a Student’s t test with two-tailed distribution.
(H) Mice (n = 4 per genotype) were immunized as in
(F) and culled 7 days after the second immuniza-
tion following which the spleens were fixed and
stained for B220 and IgG2b in serial sections.
Arrowheads indicate regions of colocalization
between B220 and IgG2b. Scale bar, 75 mm.
See also Figure S2.
Cancer Cell
ATMIN Regulates Genomic StabilityEfficient CSR Is Dependent on ATMIN
Although it is clear that treatment of cultured cells with hypotonic
stress or chloroquine leads to ATM activation (Bakkenist and
Kastan, 2003), the physiological relevance of noncanonical
ATM activation mimicked by these rather artificial conditions is
not known. Because ATM is required for efficient CSR, and
because chromatin structure is altered during CSR, we tested
whether ATMIN may function as a cofactor for ATM in this590 Cancer Cell 19, 587–600, May 17, 2011 ª2011 Elsevier Inc.process. During CSR AID initiates DSBs
in both Sm and a downstream S region,
which are then joined by NHEJ. To deter-
mine whether ATMIN is required for CSR,
we measured the surface expression of
IgG1 on B cells following stimulation
with LPS/IL4. In comparison to ATMINF/F
B cells, ATMINDB/DB B cells displayeda 50% reduction in the efficiency of CSR (Figure 2A). As a control
experiment, we stimulated ATMINF/F and ATMINDB/DB B cells
with LPS/IL4 and observed that cells from both genotypes
formed blasts with equal efficiency (Figures S2A and S2B) and
displayed comparable cell-cycle profiles (Figures S2C and
S2D). Furthermore, ATMINDB/DB B cells stimulated with LPS/
IL4 proliferated efficiently (as measured by dilution of CFSE) (Fig-
ure S2E) and did not undergo increased apoptosis, as measured
Cancer Cell
ATMIN Regulates Genomic Stabilityusing subG1 analysis (Figure S2F) as well as TMRE and TOPRO
staining (living cells are TMRE+TOPRO) (Figure S2G), com-
pared with ATMINF/F B cells. These data indicate that the
reduced efficiency of CSR is not a secondary consequence of
altered cell proliferation or death but rather reflects a defect in
recombination.
In order to address whether ATMIN functions in CSR through
ATM, we assessed the amount of CSR in WT and ATM/ cells
and found this to be reduced about 75% (Figure 2B), and this
defect was reproducible upon the treatment of ATMINF/F B cells
with an ATM small molecule inhibitor (ATMi; Ku55933) (Hickson
et al., 2004) (Figure 2C). ATMi treatment reduced CSR to the
same extent in ATMINDB/DB and control B cells, indicating that
ATMIN and ATM deficiency does not result in an additive defect
in CSR (Figures 2C and 2D).
To ensure that the defect in CSR was not due to a delay in this
process, we induced switching to either IgG1 (Figure S2H) or
IgG3 (Figure S2I) by treating cells with CD40/IL4 or LPS for
5 days, respectively. Indeed, even after 5 days of CSR induction,
ATMINDB/DB B cells maintained a 50% defect in switching. In line
with these data, ELISA revealed a 50% and 70% reduction in the
amount of IgG1 secreted into the supernatant of the ATMINDB/DB
and ATM/B cell cultures, respectively, in comparison to that of
the relative control cultures (Figure 2E).
To further confirm a CSR defect upon deletion of ATMIN, we
measured the g1 germline transcript (GLT), g1 productive tran-
script (PT), and the g1 circle transcript (CT) (Figure S2J).
Whereas the g1 GLT in ATMINDB/DB cells was not significantly
altered, the PT was greatly reduced in stimulated ATMINDB/DB
B cells (Figure S2K) as was the IgG1 CT (Figure S2L), further indi-
cating that ATMIN functions in the process of CSR in vitro. The
decrease in IgG1 CT in ATMINDB/DB B cells cultures was also
maintained when normalized to the B cell-specific gene Pax5
(Figure S2M).
To determine whether ATMIN is also required for CSR in vivo,
we immunized ATMINF/F and ATMINDB/DB mice with the antigen
TNP-KLH and then measured the amount of antigen-specific
antibodies in the serum of the mice by ELISA. ATMINDB/DB
mice displayed a 45%–65% reduction in CSR to IgG1, IgG3,
IgE, and IgG2b in comparison to ATMINF/F mice (Figure 2F),
whereas the levels of IgM were slightly elevated in ATMINDB/DB
compared with ATMINF/F mice (Figure 2G). In addition we
observed decreased staining for IgG2b (Figure 2H) in the spleens
of ATMINDB/DB mice compared with both ATMINF/F mice post-
stimulation with the antigen TNP-KLH. Taken together, the
in vitro and in vivo data identify a role for MRN-independent
noncanonical ATM activation in CSR.
Because we had identified a deficiency in the frequency of
CSR in ATMINDB/DB-stimulated B cells and in immunized mice,
we next addressed whether the accuracy of recombination
was affected. To this end, we stimulated B cells in vitro to induce
isotype switching to IgG1 and amplified Sg1-Sm junctions
(Figure S2N). The fidelity of repair was comparable between
ATMINF/F and ATMINDB/DB B cells because the frequency and
the length of microhomology at the switch junction were similar
between both genotypes (Figures S2O and S2P). We conclude
that whereas ATMINDB/DB cells show reduced efficiency of
CSR, the accuracy of recombination is intact, as is the case in
ATM/ B cells (Reina-San-Martin et al., 2004).SHM is a further mechanism used to generate antibody diver-
sity, which is also initiated by AID. However, the repair of these
lesions is thought to occur via MMR or BER and is ATM indepen-
dent, supported by the finding that it occurs normally in ATM-
deficient mouse mutants (Reina-San-Martin et al., 2004).
Although SHM is not greatly disturbed in PMS2 or MLH1 defi-
ciencies, ATMIN has been reported to affect MLH1-dependent
MMR (McNees et al., 2005), and therefore, we investigated
whether SHM could be affected in ATMINDB/DB mice. We sorted
B cells that had undergone SHM (B220+PNA+) from Peyer’s
Patches of aged mice (about 10-month-old mice were used to
allow for accumulation of mutations) and sequenced the
JH4-CH intron of the Igh locus (as depicted in Figure S2N). By
identifying 285 and 205 mutations within the JH4-CH intron
from ATMINF/F and ATMINDB/DB mice, respectively, we estab-
lished that SHM can accumulate normally in ATMINDB/DB mice
with the observed frequency of mutations being comparable to
those generated in ATMINF/F mice (Figure S3A). Furthermore,
the mutation load and the distribution of mutations identified in
59 and 50 clones for ATMINF/F and ATMINDB/DB mice, respec-
tively, were largely unchanged (Figures S3B and S3C). These
data argue against a function of ATMIN in SHM.
ATM Signaling in B Cells Requires ATMIN
We have previously shown that ATMIN is required for ATM acti-
vation in MEFs after treatment with agents that induce changes
in chromatin structure (such as chloroquine and osmotic stress),
but not after the generation of DNA DSBs by IR (Kanu and Beh-
rens, 2007). Therefore, we wanted to determine whether ATMIN
is also required for ATM activation under these conditions in B
cells. We, therefore, purified B cells from spleens of control
ATMINF/F and ATMINDB/DB mice, treated with IR (0.8 Gy) or
osmotic stress (135 mOsm NaCl) and assessed ATM activation.
ATM was activated efficiently by IR in both ATMINF/F and
ATMINDB/DB B cells, as revealed by phosphorylation of the
ATM substrate KAP1 at S824. However, ATM activation was
dramatically reduced following osmotic stress in ATMINDB/DB
cells (Figure 3A). The total levels of ATM and KAP1 proteins
were unchanged in ATMINDB/DB B cells as compared to
ATMINF/F B cells. The survival of ATMIN-deficient B cells is not
impaired in response to IR (Figure S3D), in line with our observa-
tion that ATM signaling in response to DSBs occurs normally.
During CSR presumably only a small number of DNADSBs are
generated. Although ATMIN was dispensable for ATM signaling
by higher doses of IR, it was conceivable that ATMIN may be
required for ATM signaling triggered by a small number of
DSBs similar to what occurs during CSR (Figure 3B). Therefore,
we treated B cells with 0.2 Gy IR (a dose that should only induce
an average of 7.5 DSBs per cell) and found that ATM activation,
as noted by phosphorylation of KAP1, was intact in ATMINDB/DB
B cells. Notably, ATM mRNA was increased in ATMINDB/DB B
cells compared with ATMINF/F B cells (Figure 3C), and ATM
protein was not reduced (Figure 3A).
To address whether ATMIN is required for ATM activation in
cells undergoing CSR, we stained activated B cells treated
with LPS/IL4 for P-ATM and gH2AX (Figure 3D). The localization
of activated ATM to sites of DNA damagemarked by gH2AXwas
less efficient upon loss of ATMIN (Figure 3E), providing additional
evidence supporting a role for ATMIN in ATM function.Cancer Cell 19, 587–600, May 17, 2011 ª2011 Elsevier Inc. 591
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Figure 3. ATMIN Is Required for ATM Signaling in B Cells
(A) Purified B lymphocytes from ATMINF/F and ATMINDB/DB mice were untreated, treated with 0.8 Gy IR followed with 30 min incubation at 37C, or treated with
osmotic stress (50 mM NaCl = 135 mOsm) for 1 hr at 37C. Cells were then lysed, proteins were resolved on a 3%–8% SDS-PAGE gel, and then transferred to
a nitrocellulose membrane. The membrane was probed with the indicated antibodies.
(B) Purified B lymphocytes from ATMINF/F and ATMINDB/DBmice were either left untreated or treated with 0.2 Gy IR followed with 20min incubation at 37C. Cells
were then lysed, proteins were resolved on a 3%–8% SDS-PAGE gel and then transferred to a nitrocellulose membrane. The membrane was probed with the
indicated antibodies.
(C) Quantitative RT-PCR for ATM was performed on mRNA from ATMINF/F and ATMINDB/DB B lymphocytes. Levels of ATM mRNA were normalized to actin.
(D) Purified B lymphocytes from ATMINF/F and ATMINDB/DB mice cultured with LPS/IL4 for 2 days following which cells were stained for P-S1987 ATM, gH2AX
(P-S139), and DAPI. Arrows indicate regions stained positive for gH2AX but negative for P-S1981 ATM. Scale bar, 5 mm. The quantification of 100 cells/treatment
is shown in (E). Data are presented as mean and SD. Statistical analyses were calculated by a Student’s t test with two-tailed distribution. p values are indicated.
See also Figure S3.
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A100 0   1  3 (0.03/cell)  0.04
200 31 (0.16/cell) 32 (0.16/cell) 212 (1.06/cell) 1.43
100 0  0  4 (0.04/cell) 0.04
104  9 (0.09/cell)  14 (0.13/cell) 103 (0.99/cell)  1.39
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Figure 4. Loss of ATMIN Leads to Genomic Instability in B Cells
(A–C) (A) Metaphases from ATMINDB/DB and ATM/B cells stimulated with LPS/IL4 form radial structures, dicentric chromosomes, and chromosome/chromatid
breaks and also show instability of chromosome 12, whereasWT and ATMINF/F control cells (n = 2mice/genotype) do not display such abnormalities significantly
(B and C). Deletions and translocations were observed within chromosome 12 (that carries the Igh locus) in ATMINDB/DB but not ATMINF/F metaphase cells
stimulated with LPS/IL4 to induce CSR (identified using a painting probe for chromosome 12, a telomere probe, a BACprobe for Igh, andDAPI). Of 62 ATMINDB/DB
metaphases that showed aberrations within chromosome 12, 4 had putative Igh aberrations (positive for IghCa probe and negative for telomere probe), and
27 showed non-Igh aberrations (negative for both IghCa and telomere probes). In ATM/ B cells, putative Igh aberrations occurred in 2 of 39 metaphases
compared to 13 of 39 non-Igh aberrations. Scale bar, 2 mm.
(D) Using M-FISH, genomic instability represented by duplications, translocations, and deletions was observed in ATMINDB/DB metaphase cells stimulated with
LPS/IL4 to induce CSR but not in ATMINF/F control cells (n = 4 per genotype for ATMINF/F and ATMINDB/DB, n = 4 per genotype for WT and ATM/).
See also Figure S4.
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Because ATM function is required to suppress chromosomal
translocations, we next asked whether ATMIN is required to
suppress genomic instability. For this purpose we arrested
ATMINF/F and ATMINDB/DB cells in metaphase following CSR
and stained with a telomere probe, Igh probe (containing
Cd-Ca of the Igh locus), and a painting probe for chromosome
12 (that carries the Igh locus) combined with DAPI. We observedfusions, translocations, and deletions both within chromosome
12 and within other chromosomes in ATMINDB/DB B cells
compared with ATMINF/F B cells (Figures 4A and 4B). A compar-
ison of the instability of ATMINDB/DB B cells with ATM/ B cells
revealed that deletion of either gene resulted in the formation of
radial structures, dicentric chromosomes, and chromosome/
chromatid breaks (Figure 4A; Figure S4A), with comparable
frequencies. Therefore, similar to ATM, ATMIN is required toCancer Cell 19, 587–600, May 17, 2011 ª2011 Elsevier Inc. 593
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Figure 5. ATMIN Is Required to Repair RAG1/2-Induced Breaks
in Peripheral B Cells
(A) Using a painting probe for chromosome 16, 30Igl probe in green and 50Igl
probe in red, the repair of RAG1/2-induced breaks was measured.
(B) 3D FISH was performed on unstimulated and 3 day LPS-stimulated
ATMINDB/DB and ATM/ B cells along with their controls using probes located
in the 50 and 30 of the Igl locus. Scale bar, 1 mm.
(C) Quantification of (B). p values were calculated using the chi-square test.
See also Figure S5.
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observed in chromosomes other than chromosome 12, sug-
gesting that ATMIN is required for maintaining global genomic
stability of B cells (Figures 4B and 4C). In order to determine
which chromosomes were involved in the instability that was
not associated with chromosome 12, we performed multiplex-
fluorescence in situ hybridization (M-FISH) and found a number
of chromosomes to be duplicated (trisomy), translocated, and
deleted. Examples of each form of instability are shown in Fig-
ure 4D (the complete M-FISH profiles of ten ATMINDB/DB, ten
ATM/, six ATMINF/F, and six WT B are shown in Figures
S4B–S4E).
It has recently been demonstrated that peripheral B cells
attempt secondary V(D)J recombination and that activated
NHEJ-deficient splenic B cells accumulate V(D)J recombina-
tion-associated breaks at the Igl locus (Wang et al., 2009). To
assess the stability of the Igl locus in basal conditions
and following CSR, we performed 3D FISH on ATMINDB/DB and
ATM/ cells along with their respective controls using 30 and
50 Igl probes (Figure 5A). Using this approach, we found that
both ATMIN and ATM are required to maintain stability of the
Igl locus in peripheral B cells that undergo secondary V(D)J
recombination. Normally the 50 and 30 Igl probes colocalize on
both alleles (Figure 5B). However, following the induction of
CSR, RAG1/2 induces peripheral B cells to undergo secondary
V(D)J recombination of Igl, and the repair of these breaks
appears to occur with decreased efficiency in the absence of
ATMIN or ATM, leading to increased incidence of broken Igl
loci compared to controls (Figure 5C; Figure S5). These data
further demonstrate the requirement for ATMIN in maintaining
the global genomic stability of B cells.
Deletion of ATMIN in BCells Results in B Cell Lymphoma
DSBs are formed in Ig loci during antibody gene diversification
reactions, and a defect in the repair of these breaks tends to lead
to oncogenic Ig translocations in several mouse models for DNA
repair genes (Callen et al., 2007a, 2009;Celeste et al., 2002;Difilip-
pantonio et al., 2000, 2002; Difilippantonio et al., 2005; Reina-San-
Martin et al., 2005). However, such translocations have often only
been observed in cultured cells, and loss-of-function mouse
models for many repair genes have not been reported to generate
B cell lymphomas in vivo. Indeed, the humanizedmousemodel for
NBS1 (hNbs1657D5) develops B cell and thymic lymphomas only in
a p53/ background (Reina-San-Martin et al., 2005). In contrast,
approximately 40% of ATMINDB/DB mice develop B cell
lymphomas at around 6 months of age (Figure 6A), as character-
ized by a dramatic increase in the size of the spleen in comparison
to that of ATMINF/F littermates (Figure 6B).
H&E of the spleens from ATMINDB/DB mice with B cell
lymphomas demonstrated a disorganized structure, with the
germinal centers (GCs) being largely indistinguishable from the
red pulp (RP) (Figure 6C). The development of lymphoma was
confirmed by the infiltration of B cells tomultiple organs including
the lungs, as shown by B220 staining (Figure 6D). Furthermore,
the tumor cell infiltrates to the liver were positive for B220
but negative forCD3 andMac2, hence confirming that the tumors
were of aBcell origin andnot of aTcell ormacrophageorigin (Fig-
ure S6). The infiltration of tumor cells was particularly apparent
around the blood vessels, as indicated in the liver (Figure S6).594 Cancer Cell 19, 587–600, May 17, 2011 ª2011 Elsevier Inc.To determine the expression profile of ATMIN in the spleen, we
performed in situ hybridization. In 6-week-old ATMINF/F control
mice, atmin mRNA expression was confined mostly to the GCs
(Figure 6E). atminmRNAwasabsent inATMINDB/DB spleens, indi-
cating that B cells express high levels of atmin mRNA (and also
serving as a negative control for the specificity of the in situ
hybridization, Figure 6E). Spleens from ATMINDB/DB mice with B
cell lymphoma showed no atmin expression, hence indicating
that the lymphoma originated from ATMINDB/DB cells.
To assess the tumorigenic potential of B cells fromATMINDB/DB
mice with B cell lymphomas, we engrafted total splenocytes into
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Figure 6. ATMIN Is Required to Suppress
B Cell Lymphoma
(A) ATMINDB/DB mice develop B cell lymphoma at
a mean age of 6.5 months. Log rank (Mantel-Cox)
test was used to compare ATMINF/F to
ATMINDB/DB (p = 0.0178).
(B) Macroscopic analysis of spleens from
ATMINDB/DB mice with B cell lymphoma
(ATMINDB/DB T1) compared with age-matched
ATMINF/F mouse (scale bar, 1 cm).
(C) H&E and B220 staining of the spleen from
ATMINF/F and ATMINDB/DB T1mice revealed a loss
of discrete GCs and RP regions, in the latter case.
Scale bar, 100 mm.
(D) H&E and B220 staining of the lungs displayed
an infiltration of B220+ but also B220 cells in
ATMINDB/DB T1. Scale bar, 100 mm. The dashed
lines and boxes in (C) and (D) indicate regions that
are represented in the panels below at higher
magnification.
(E) In situ hybridization for atmin indicates its
localization mainly to the GCs of ATMINF/F spleens
and that expression is lost in spleens from
ATMINDB/DB and ATMINDB/DB T1 mice. Scale bar,
100 mm.
(F) ATMINDB/DB lymphomas are transplantable.
Schematic representation for the engraftment of
ATMINF/F or ATMINDB/DB B cell lymphoma into
sublethally irradiated NuNu mice.
(G) Splenocytes from ATMINDB/DB B cell
lymphomas but not splenocytes from ATMINF/F
are transplantable as indicated by infiltration of B
cells to the lungs (indicated by arrow). ATMINDB/DB
T1–T4 were transplanted individually into three
host NuNu mice. ATMINDB/DB T1 engraftment is
indicated in the figure as a representative result.
Scale bar, 100 mm.
See also Figure S6.
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post-engraftment, recipientmice receiving cells from the spleens
of moribund ATMINDB/DB mice, but not those receiving ATMINF/F
control splenocytes, appeared moribund and were culled. InCancer Cell 19, 587–these moribund mice the spleens were
slightly increased in size, and lymphoma
cells were found in multiple tissues,
including the lungs and liver (Figure 6G;
data not shown). Hence, transplantation
of ATMINDB/DB splenocytes causes
lymphoid tumor development in host
animals, confirming their tumorigenic
potential in vivo. Thus, deletion of ATMIN
in B cells leads to the formation of B cell
lymphoma.
ATMINDB/DB B Cell Lymphomas Are
Phenotypically Diverse and Carry
Global Genomic Instability
If ATMIN is required for maintaining global
genomic instability, this would imply that
the B cell lymphomas that develop due
to loss of ATMIN should be phenotypi-cally diverse. FACS analyses of spleens from ATMINDB/DB mice
with B cell lymphomas revealed that this was indeed the case
(Figure 7A; Figure S7). Furthermore, M-FISH analyses demon-
strated that tumor cells harbored genomic aberrations of600, May 17, 2011 ª2011 Elsevier Inc. 595
Phenotype and Karyotype of B cell Lymphomas
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Figure 7. ATMINDB/DB Lymphomas Arise Due to Genomic Instability
(A) Phenotypic FACS analysis of lymphomas indicates them to be heterogeneous.
(B) Cells from ATMINDB/DB mice with B cell lymphomas (ATMINDB/DB T1–T6) were analyzed by M-FISH and DAPI staining to identify cytogenetic abnormalities.
del, deletions; break, chromosome/chromatid breaks/gaps; fusion, dicentric chromosomes; T, translocations. At least five metaphases were analyzed.
(C) Southern blot for JH region of the Igh locus using DNA isolated from ATMINDB/DB B cell lymphomas. The arrows on the right of each panel indicate bands
specific for the rearranged Igh locus.
(D) Model for the role of ATMIN in suppressing translocations.
See also Figure S7.
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ure 7B). Southern blotting for the JH region of the Igh locus indi-
cated these B cell lymphomas to be mostly monoclonal
(Figure 7C).
DISCUSSION
Using a mouse model lacking ATMIN function in B cells, we have
shown that ATMIN is required during the maturation of B cells
and for the repair of breaks that are generated during CSR.
Furthermore, ATMINDB/DB mice develop B cell lymphomas, and
ATMINDB/DBBcells arecharacterizedbyglobalgenomic instability.
Similar Phenotypes of ATM and ATMIN Deficiency
in B Cells
The ATMINDB/DB phenotype shares several similarities with
ATM deficiency. First, like ATM, ATMIN is required during the
early maturation of B cells; however, both ATMINDB/DB mice
and ATM/ mice have normal numbers of mature splenic B
cells (Figure 1; Figures S1F–S1J) (Xu et al., 1996). Second,
both ATMIN and ATM are required for efficient CSR (Figure 2;
Figures S2A–S2M), but the fidelity of repair at switch junctions
is unaffected in both ATM/ and ATMINDB/DB B cells (Figures
S2O and S2P) (Reina-San-Martin et al., 2004). Third, the
efficiency of generating antibody diversity by SHM of the
variable region of the Igh locus is unaffected by both ATMIN
and ATM deficiency (Figures S3A–S3C) (Reina-San-Martin
et al., 2004). Finally, the genomic in stability observed in
ATMINDB/DB B cells is similar both quantitatively and qualita-
tively to that observed in ATM/ cells (Figures 4, 5, Figures
S4B–S4E, and S5). Taken together, the similarities shared
between ATMINDB/DB mice and ATM/ mice, together with
the reduced ATM activity in response to hypotonic stress, indi-
cate that ATMIN has physiological relevance for ATM function
in B cells. However, it is worth noting that ATM-independent
functions of ATMIN may well contribute to the phenotype in
ATMINDB/DB mutant mice.
Functional Significance of DSB-Independent ATM
Activation
The ATM-signaling pathway can be triggered by different stimuli.
The best-characterized pathway of ATM activation is the
response to DSBs, experimentally induced by IR andmany other
agents such as topoisomerase inhibitors. But in addition to
DNA breaks, ATM activation is also triggered by hypotonic
stress that induces chromatin conformation changes (Bakkenist
and Kastan, 2003). NBS1 null B cells are defective in ATM
signaling after IR, but ATM activation in response to hypotonic
stress is intact (Difilippantonio et al., 2005). The requirement of
ATMIN for ATM activity appears to be complementary to
NBS1. The activation of ATM after hypotonic stress is mediated
by ATMIN, whereas ATM activation following IR is normal in
ATMINDB/DB cells (Figures 3A and 3B). Thus, ATMIN deficiency
inactivates the arm of ATM signaling triggered by hypotonic
stress in B cells.
Although MRN-dependent ATM activation is triggered by
DSBs, at present, the molecular signal triggering ATMIN-
dependent ATM activation is not known. ATM signaling induced
by hypotonic stress is defective in both ATMIN-deficient murineMEFs and B cells, as well as in HEK293T cells transfected with
sh-ATMIN knockdown constructs (Kanu and Behrens, 2007).
Thus, the pathway of ATM activation mimicked by hypotonic
stress is unlikely to be B cell specific but rather a second
generic mode of ATM activation. Hypotonic stress and chloro-
quine are believed to act by altering chromatin structure
(Bakkenist and Kastan, 2003), and the identification of the chro-
matin-based stimulus of ATMIN-dependent ATM activation will
be required for a complete understanding of ATMIN and ATM
functions.
Nonredundant Biological Functions of ATMIN and NBS1
Although both ATMINDB/DB and NBS1DB/DB B cells have a 50%
defect in CSR, ATM/ B cells have a more dramatic defect
(around 70%–80% reduction) (Figure 2D) (Kracker et al., 2005;
Lumsden et al., 2004; Reina-San-Martin et al., 2004, 2005).
The inhibition of ATM in ATMINDB/DB cultures reduces the
amount of CSR to levels comparative to ATM/ cultures, i.e.,
the effects of ATM and ATMIN deficiencies are not additive.
This is in agreement with the notion that ATMIN functions at least
in part through regulation of ATM signaling during CSR. Their
nonredundant biological functions indicate that for efficient
ATM-dependent CSR to occur, both ATMIN and NBS1 are
required. This implies that canonical ATM activation and nonca-
nonical ATM activation are both essential during CSR. The
nonoverlapping functions of ATMIN and NBS1 might reflect
functions at different stages and/or different aspects of CSR.
A further difference between ATMINDB/DB mice and a mouse
model for patients with NBS, in which a 5 bp hypomorphic allele
is expressed in an NBS null background (hNbs1657D5), is that
whereas both models display genomic instability, ATMINDB/DB
mice develop B cell lymphomas, but hNbs1657D5 mice only
develop B and T cell lymphomas in a p53/ background
(Difilippantonio et al., 2005). T cell thymomas are the main cause
of lethality of ATM/ mice and occur due to defective TCR
rearrangement (Barlow et al., 1996; Liyanage et al., 2000; Matei
et al., 2007; Xu et al., 1996). In contrast, deletion of NBS1 in
T cells does not lead to the formation of thymomas (Saidi
et al., 2010). Our unpublished data indicate that deletion of
ATMIN using a Vav-cre transgene that deletes from the hemato-
poietic stem cell onward does lead to the development of
T cell lymphomas, albeit with low penetrance. However, whether
this is due to defective TCR rearrangement remains to be
shown. Hence, whereas both ATMIN and NBS1 are required to
maintain genomic stability, absence of ATMIN and ATM in
immune cells leads to the generation of lymphomas, whereas
in the case of NBS1 deletion, a further oncogenic hit appears
to be required.
ATMIN Function in B Cell Lymphoma
We show that the absence of ATMIN in B cells leads to the devel-
opment of B cell lymphomas (Figures 6 and 7; Figures S6 and
S7). ATMINDB/DB mice reveal a role for ATMIN in the repair of
both RAG1/2 and AID-induced breaks in peripheral B cells
(Figures 4 and 5). In the absence of ATMIN, breaks generated
by peripheral V(D)J rearrangement and CSR are inappropriately
repaired, resulting in translocations, deletions, fusions, and
chromatid/chromosome breaks and gaps, ultimately leading to
B cell lymphoma.Cancer Cell 19, 587–600, May 17, 2011 ª2011 Elsevier Inc. 597
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reported to result from RAG1/2-dependent Igh-associated
breaks that can persist throughout B cell development
(Callen et al., 2007b). We are using CD19-cre to delete ATMIN,
which mediates deletion from the pro-B cell stage, when Igh
rearrangement should be largely completed. Thus, we hypothe-
size that the genomic instability in ATMINDB/DB B cells is
mainly a result of AID-induced breaks that are not efficiently
repaired. However, we have also observed that ATMIN is
required for repair of breaks caused by peripheral V(D)J recom-
bination induced by RAG1/2 (Figure 5). Thus, Igl breaks may
persist in ATMIN-deficient B cells and contribute to genomic
instability.
The ATMINDB/DB lymphomas are heterogeneous, as is the
case with somemodels of B cell lymphoma, including transgenic
mice overexpressing AID (Figure 7; Figure S7) (Robbiani et al.,
2009). Furthermore, genomic instability was found to occur on
chromosomes other than those carrying immunoglobulin loci.
This raises the possibility that ATMIN might function as a tumor
suppressor also in nonlymphoid tissues.
It is puzzling that ATMINDB/DBmice develop B cell lymphomas,
whereas ATM/ mice do not. However, homozygous mice
harboring an in-frame deletion of ATM corresponding to the
human 7636 del9 mutation show an increased susceptibility to
developing tumors, including B cell lymphoma (Spring et al.,
2001, 2002). Also, A-T patients exhibit a predisposition to the
development of a wide range of lymphoid tumors of both T and
B cell origin (Stankovic et al., 2002). Thus, it appears that the
nature of the ATM mutation determines the tumor spectrum.
ATM activity is believed to have two main functions in the
suppression of CSR-associated chromosomal translocations.
First, ATM has been suggested to facilitate CSR by stabilizing
the synapsis of distal switch regions, and therefore, the absence
of ATM may increase the frequency of abnormal translocations
(Callen et al., 2007a). Second, ATM signaling has been shown
to constitute a barrier against oncogenic transformation.
Increased expression of oncogenes as a result of aberrant
translocations can lead to oncogenic stress and induces an
ATM-dependent DNA-damage response (Bartkova et al., 2005,
2006; Mallette et al., 2007). Thus, the ATM-dependent check-
point may antagonize lymphoma development by eliminating
cells before or after they suffer an oncogenic translocation.
The relative contribution of ATMIN and NBS1 for ATM function
in tumor suppression is not known.
Interestingly, analysis of atmin expression using published
data describing transcriptional profiling of human patients with
B cell acute lymphoblastic leukemia (B-ALL) revealed that the
expression of atmin was reduced in B-ALL as compared to
normal pre-B and immature B cells (Maia et al., 2005). Thus,
reduced atmin expression may also contribute to the develop-
ment of human B cell lymphomas.
This study has revealed an important function for ATMIN in B
cells. We have shown that ATMIN is required to prevent chromo-
somal instability in B cell lymphoma. A better understanding of
chromosomal instability in lymphoid cancers and how tumor-
suppressive pathways normally limit the frequency of these
aberrant recombination events will be crucial for the develop-
ment of more efficient chemotherapeutics (Bunting et al., 2010;
Nussenzweig and Nussenzweig, 2010).598 Cancer Cell 19, 587–600, May 17, 2011 ª2011 Elsevier Inc.EXPERIMENTAL PROCEDURES
Mice
Mice with a targetedmutation of the atmin gene were generated by insertion of
lox P sequences upstream and downstream of exon 4 of atmin (ATMINF) in
embryonic stem (ES) cells, injection of ATMINWT/F into blastocysts, andmating
of the resulting chimera. For cre-mediated deletion of atmin in B lymphocytes,
ATMINF/F mice were crossed with heterozygous CD19-cre mice and were
designated ATMINDB/DB. ATM mice were bred as ATM+/ and have been
described previously (Barlow et al., 1996). Immunocompromised ICRF NuNu
mice were maintained in-house. Unless otherwise stated, all mice were used
at 6–12 weeks of age. CD19-cre deletion efficiency and genotyping of mice
were determined using a PCR-based assay using primers specific for the
floxed exon 4, deleted exon 4, and WT atmin alleles as well as primers for
CD19-cre and WT CD19 alleles using the primers:
Lox6133F 50-TCAGCATCTTCTCCAGAGAGACAG-30,
Lox6617R 50-CACATGTGTACAGCACATTCATTG-30,
Lox10252R 50-CTCAGGGTACACATACTATGCTTGC-30
CD1902 50-CCACAGAGGGAGGCAATGTTGTGC-30
CD19.15R 50-GTCCTTGAAAGGGGGCCTCTTCTGGC-30
Cre19.2R 50-ACGACCGGCAAACGGACAGAAGCA-30
Animals were maintained and bred in the London Research Institute Biolog-
ical Resources. All experimental procedures were approved by London
Research Institute ethics committees and conform to the UK Home Office
regulations.
Immunizations
Micewere immunized as described previously (Lumsden et al., 2004) with slight
modifications.Briefly,micewere injected intraperitoneallywith100mgTNP-KLH
(Biosearch Technologies Inc.) in Imject Freunds Complete Adjuvant (FCA) (at
a ratio of 1:1 [Thermo Scientific]), and serum was collected on day 0 before
immunization and on days 7, 14, 21, and 39 after immunization. Mice were
boosted in the samemanner on day 40, and serumwascollected onday7. Total
and antigen-specific serum immunoglobulins were assayed by ELISA.
Engraftment of B Cell Lymphomas
Splenocytes (8.53 106 cells in 100 ml) from four control ATMINF/Fmice and four
ATMINDB/DBmice with B cell lymphomas (T1–T4) were injected into the tail vein
of sublethally irradiated (374 rad) NuNu recipients (three recipients per host
sample). Around 2-4 months postinjection mice injected with ATMINDB/DB
T1–T4 splenocytes, but not ATMINF/F splenocytes, became moribund and
were culled.
Purification, In Vitro Activation, and Treatment of B Cells
Single-cell suspensions of B lymphocytes were generated from murine
spleens by lysis of red blood cells using ammonium chloride (STEMCELL
Technologies) and negative selection following incubation with biotin-conju-
gated antibodies (CD4, CD8, TCRb, TCRgd, CD49b, Mac1, Ter119 [BD
PharMingen]) and then streptavidin-conjugated Dynabeads (Invitrogen). For
in vitro activation, B lymphocytes were cultured at 1 3 106 cells/ml in RPMI
1640 medium (Invitrogen) supplemented with penicillin/streptomycin
(Invitrogen), L-glutamine (Invitrogen), 10% FCS (Sigma), and 5 3 105 M
b-mercaptoethanol (Sigma) with 15 mg/ml Escherichia coli lipopolysaccharide
(LPS; Sigma) with or without 50 ng/ml IL4 (Sigma) and CD40L at 100ng/ml
(R&D Systems). The ATM inhibitor Ku55993 (Hickson et al., 2004) (Merck)
was used at 10 mM throughout the culture duration. IR experiments were
performed using a Cs137 Gamma Irradiator for the indicated times. Hypotonic
swelling was performed using 50 mM NaCl (135 mOsm) in 1% FBS/PBS
supplemented with 0.45% glucose for 1 hr at 37C as described previously
(Difilippantonio et al., 2005). Cells were incubated for the indicated time points
before FACS analysis, ELISA, or extraction of DNA, RNA, or protein.
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